Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the side effects of rezdiffra?

See the DrugPatentWatch profile for rezdiffra

Common Side Effects of Rezdiffra

Rezdiffra (resmetirom), approved for noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis, most often causes nausea, diarrhea, abdominal pain, fatigue, and nasopharyngitis (like a stuffy nose or sore throat). These affect 10-20% of patients in trials and are usually mild to moderate.[1][2]

Serious Side Effects and Risks

Serious issues include gallbladder disease (cholelithiasis or cholecystitis), seen in up to 9% of users, which may require surgery. Drug-induced liver injury occurred in 0.7% of trial participants. Other risks: elevated liver enzymes, thyroid issues, and potential for muscle damage (rhabdomyolysis) with statins. Avoid in patients with decompensated cirrhosis or recent liver decompensation.[1][3]

Side Effects by Frequency from Clinical Trials

  • Very common (>10%): Diarrhea, nausea.[2]
  • Common (1-10%): Vomiting, constipation, abdominal discomfort, fatigue, viral infections, weight loss, dizziness, COVID-19, hypertension.[1][2]
  • Uncommon (<1%): Gallbladder problems, elevated ALT/AST, hypersensitivity reactions.[3]

    Trials (MAESTRO-NASH/NAFLD) tracked over 900 patients; side effects led to discontinuation in 6.5% vs. 2.6% on placebo.[2]

How Long Do Side Effects Last?

Most gastrointestinal effects start early and resolve within weeks as patients adjust. Gallbladder issues can persist or worsen, needing monitoring via ultrasound every 3 months initially.[1][3]

Side Effects in Special Populations

Pregnant patients face fetal harm risks—use contraception. No data in kids under 18. Dose adjustments needed for severe kidney impairment. Common in older adults (65+), with higher fatigue rates.[1]

Managing Side Effects

Take with food to reduce nausea/diarrhea. Monitor liver function monthly for first 3 months, then quarterly. Report persistent symptoms; statins require dose cuts or alternatives.[3]

Sources
[1]: Rezdiffra Prescribing Information (Madrigal Pharmaceuticals)
[2]: MAESTRO-NASH Phase 3 Trial Results (NEJM)
[3]: Drugs.com - Rezdiffra Side Effects



Other Questions About Rezdiffra :

How does rezdiffra treat mash? How does rezdiffra treat liver disease? How does rezdiffra treat nash?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy